AI Agents Enhancing Clinical Decision-Making in Oncology
June 21, 2025AI agents are improving clinical decision-making in oncology, achieving 91% accuracy in simulated patient cases. ๐ค๐
Artificial intelligence-based tumor size measurement on mammography: agreement with pathology and comparison with human readers’ assessments across multiple imaging modalities.
June 21, 2025AI tumor size measurement shows 52% discordance with pathology in breast cancer. ๐๐ค Further refinement needed.
AI Tool Enhances Skin Cancer Detection for Physicians
June 20, 2025AI tool PanDerm improves skin cancer detection accuracy by 11% for doctors, aiding early diagnosis and treatment. ๐ฉบ๐
Recent advances and challenges in colorectal cancer: From molecular research to treatment.
June 20, 2025Colorectal cancer's global impact: 1.9 million cases in 2020. AI and organoids offer hope amid treatment challenges. ๐งฌ๐
Call for Enhanced FDA Regulation of AI in Healthcare
June 20, 2025Title: FDA Regulation of AI in Healthcare Needs Improvement ๐ฅ๐คExperts urge the FDA to enhance oversight of AI tools to ensure patient safety and address biases.
The Next Frontiers in Preventive and Personalized Healthcare: Artificial Intelligent-Powered Solutions.
June 20, 2025AI in healthcare: Enhancing diagnostics, treatment, and patient outcomes through data-driven insights and real-time monitoring. ๐๐ค
Data extraction from free-text stroke CT reports using GPT-4o and Llama-3.3-70B: the impact of annotation guidelines.
June 20, 2025GPT-4o outperforms Llama-3.3-70B in stroke CT report data extraction, precision improved with annotation guidelines. ๐๐ง
North Bristol NHS Trust Achieves Milestone with Over 9,000 Robotic Surgeries
June 19, 2025North Bristol NHS Trust has completed over 9,000 robotic surgeries, enhancing patient care and reducing waiting times. ๐ค๐ฅ
Personalized translational medicine: Investigating YKL-40 as early biomarker for clinical risk stratification in hepatocellular carcinoma recurrence post-liver transplantation.
June 19, 2025YKL-40 shows promise as a biomarker for HCC recurrence post-liver transplantation, enhancing risk stratification. ๐๐